v2.3.0.11
Consolidated Statements Of Cash Flows (USD $)
In Thousands
 9 Months Ended
Jun. 25, 2011
Jun. 26, 2010
OPERATING ACTIVITIES    
Net income $ 129,581 $ 74,161
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 51,038 51,026
Amortization 175,320 171,299
Non-cash interest expense - amortization of debt discount and deferred financing costs 57,363 66,879
Stock-based compensation expense 27,245 24,524
Excess tax benefit related to exercise of non-qualified stock options (3,268) (1,828)
Deferred income taxes (35,346) (48,304)
Gain on sale of intellectual property, net (84,502)  
Impairment of cost-method investments 2,445  
Loss on extinguishment of debt 29,891  
Fair value adjustments to contingent consideration (3,546)  
Fair value write-up of inventory sold 3,298  
Loss on disposal of property and equipment 1,820 2,303
Loss on divestiture   341
Other non-cash activity (1,185) 1,387
Changes in operating assets and liabilities:    
Accounts receivable 12,120 (4,713)
Inventories (34,731) (11,222)
Prepaid income taxes 3,944 (7,255)
Prepaid expenses and other assets 1,358 437
Accounts payable (8,361) 6,064
Accrued expenses and other liabilities 9,548 (7,583)
Deferred revenue 3,083 20,425
Net cash provided by operating activities 337,115 337,941
INVESTING ACTIVITIES    
Acquisition of business, net of cash acquired (189,800)  
Payment of additional acquisition consideration (19,660)  
Divestiture of business, net of cash transferred to the buyer 1,129 (2,164)
Purchase of insurance contracts (5,322) (5,322)
Proceeds from sale of intellectual property 13,250 72,250
Purchase of other intangible assets (3,021) (500)
Proceeds from sale of cost-method investment   678
Purchase of cost-method investment (99) (721)
Purchase of property and equipment (21,894) (19,686)
Increase in equipment under customer usage agreements (20,641) (14,661)
Decrease in restricted cash 385 69
Net cash (used in) provided by investing activities (245,673) 29,943
FINANCING ACTIVITIES    
Repayments under credit agreement   (174,167)
Payment of debt issuance costs (5,327)  
Repayments of notes payable (1,015) (2,504)
Payment of contingent consideration (4,295)  
Purchase of non-controlling interests   (2,683)
Net proceeds from issuance of common stock pursuant to employee stock plans 24,078 11,294
Excess tax benefit related to exercise of non-qualified stock options 3,268 1,828
Payment of employee restricted stock tax withholding requirements (10,394) (2,522)
Net cash provided by (used in) financing activities 6,315 (168,754)
Effect of exchange rate changes on cash and cash equivalents 419 (948)
Net increase in cash and cash equivalents 98,176 198,182
Cash and cash equivalents, beginning of period 515,625 293,186
Cash and cash equivalents, end of period $ 613,801 $ 491,368